HIV integrase inhibitors
US6403347B1 · kind B1 · utility
14Cited by
0References
4Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Oct 25, 1999 |
| Grant date | Jun 11, 2002 |
| Priority date | — |
| Expiry date | Oct 25, 2019 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K31/35
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Natural products such as certain chaetochromins are described. These compounds are useful in the inhibition of HIV integrase, the prevention or treatment of infection by HIV and the treatment of AIDS, either as compounds, pharmaceutically acceptable salts, pharmaceutical composition ingredients, whether or not in combination with other antivirals, immunomodulators, antibiotics or vaccines. Methods of treating AIDS and methods of preventing or treating infection by HIV are also described.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.